We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Time for a Change

28 June 2016 By Jeffrey Goldfarb

The $40 bln drug distributor is carving out its languishing healthcare IT business and merging it with one owned by LBO firms Blackstone and Hellman & Friedman. Cost cuts and attentive management should help make it more valuable. Only excessive debt might impede a full recovery.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)